DK0382403T3 - Ekspressionssystemer til et amiderende enzym - Google Patents

Ekspressionssystemer til et amiderende enzym

Info

Publication number
DK0382403T3
DK0382403T3 DK90301034T DK90301034T DK0382403T3 DK 0382403 T3 DK0382403 T3 DK 0382403T3 DK 90301034 T DK90301034 T DK 90301034T DK 90301034 T DK90301034 T DK 90301034T DK 0382403 T3 DK0382403 T3 DK 0382403T3
Authority
DK
Denmark
Prior art keywords
amidating enzyme
expression systems
amidating
expression
enzyme
Prior art date
Application number
DK90301034T
Other languages
English (en)
Inventor
Arthur H Betelsen
Nozer M Mehta
Gary Agide Beaudry
Original Assignee
Unigene Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unigene Lab Inc filed Critical Unigene Lab Inc
Application granted granted Critical
Publication of DK0382403T3 publication Critical patent/DK0382403T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/17—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with reduced ascorbate as one donor, and incorporation of one atom of oxygen (1.14.17)
    • C12Y114/17003—Peptidylglycine monooxygenase (1.14.17.3)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Hardware Redundancy (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
DK90301034T 1989-02-06 1990-02-01 Ekspressionssystemer til et amiderende enzym DK0382403T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/307,366 US5789234A (en) 1987-08-14 1989-02-06 Expression systems for amidating enzyme

Publications (1)

Publication Number Publication Date
DK0382403T3 true DK0382403T3 (da) 2005-03-21

Family

ID=23189439

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90301034T DK0382403T3 (da) 1989-02-06 1990-02-01 Ekspressionssystemer til et amiderende enzym

Country Status (14)

Country Link
US (1) US5789234A (da)
EP (1) EP0382403B1 (da)
JP (1) JPH0771498B2 (da)
KR (1) KR0157983B1 (da)
AT (1) ATE283922T1 (da)
CA (1) CA2009306C (da)
DE (1) DE69034179T2 (da)
DK (1) DK0382403T3 (da)
ES (1) ES2235149T3 (da)
FI (1) FI110517B (da)
HU (1) HU220464B1 (da)
LT (1) LT4077B (da)
NO (1) NO900531L (da)
RU (1) RU2129606C1 (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789234A (en) * 1987-08-14 1998-08-04 Unigene Laboratories, Inc. Expression systems for amidating enzyme
US5912014A (en) * 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
HUP0001272A3 (en) 1997-04-16 2012-12-28 Unigene Lab Inc Direct expression of peptides into culture media
US8088734B2 (en) 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
DE602004024122D1 (de) * 2003-09-25 2009-12-24 Monsanto Technology Llc Verhinderung des einbaus von nichtstandard-aminosäuren in protein
US7531518B2 (en) * 2004-05-14 2009-05-12 Unigene Laboratories Inc. Method for fostering bone formation and preservation
US7648965B2 (en) 2004-05-14 2010-01-19 Unigene Laboratories Inc. Method for fostering bone formation and preservation
US20060089723A1 (en) * 2004-10-25 2006-04-27 Murphy Kieran P Method for bone augmentation
US7445911B2 (en) 2004-11-24 2008-11-04 Unigene Laboratories Inc. Enzymatic reactions in the presence of keto acids
DE102004058306A1 (de) * 2004-12-01 2006-07-27 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung von Carboxy-terminal amidierten Peptiden
PA8660701A1 (es) 2005-02-04 2006-09-22 Pfizer Prod Inc Agonistas de pyy y sus usos
US20080160577A1 (en) * 2005-02-04 2008-07-03 Glaxo Group Limited Optimization of Heterologous Polypeptide Expression
US20060293667A1 (en) * 2005-05-19 2006-12-28 Agnes Vignery Bone implant device and methods of using same
EP1907561B1 (en) * 2005-06-24 2013-08-28 Unigene Laboratories, Inc. Cell lines for expressing enzyme useful in the preparation of amidated products
US8377863B2 (en) 2007-05-29 2013-02-19 Unigene Laboratories Inc. Peptide pharmaceutical for oral delivery
CN102292346B (zh) 2009-01-22 2015-12-02 关键生物科学有限公司 肥胖的治疗
US9096843B2 (en) 2009-12-01 2015-08-04 Novo Nordisk A/S Peptidyl α-hydroxyglycine α-amidating lyases
TW201138808A (en) 2010-05-03 2011-11-16 Bristol Myers Squibb Co Serum albumin binding molecules
PL2720707T3 (pl) 2011-06-15 2019-06-28 Resother Pharma Aps Przeciwzapalne produkty farmaceutyczne
MX351092B (es) 2011-11-02 2017-10-02 Keybioscience Ag Analogos peptidicos para tratar enfermedades y trastornos.
EP3095484B1 (en) 2011-11-02 2018-05-02 KeyBioscience AG Calcitonin mimetics for treating diseases and disorders
US9533022B2 (en) 2011-11-02 2017-01-03 KeyBioscience A/S Peptide analogs for treating diseases and disorders
ES2774962T3 (es) 2013-03-05 2020-07-23 Enteris Biopharma Inc Productos farmacéuticos de administración oral
KR20160075794A (ko) 2013-11-14 2016-06-29 키바이오사이언스 아게 질환 및 질병 치료용 칼시토닌 모방체
JP2016540762A (ja) 2013-12-02 2016-12-28 ステルス バイオセラピューティックス コープ 白斑の治療のための組成物及び方法
CA2950410A1 (en) 2014-05-28 2015-12-03 D. Travis Wilson Therapeutic compositions including therapeutic small molecules and uses thereof
EP3501532A3 (en) 2014-05-28 2019-07-17 Stealth BioTherapeutics Corp Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
US10627392B2 (en) 2014-06-17 2020-04-21 Stealth Biotherapeutics Corp Methods of identifying and monitoring mitochondrial dysfunction using monocyte screening
GB201500263D0 (en) 2015-01-08 2015-02-25 Keybioscience Ag Calcitonin analogues for treating diseases and disorders
JP6910950B2 (ja) 2015-01-12 2021-07-28 エンテリス・バイオファーマ・インコーポレイテッドＥｎｔｅｒｉｓ Ｂｉｏｐｈａｒｍａ，Ｉｎｃ． 固形経口剤形
GB201704429D0 (en) 2017-03-21 2017-05-03 Keybioscience Ag Calcitonin mimetics for treating diseases and disorders
GB201707955D0 (en) 2017-05-18 2017-07-05 Keybioscience Ag Dual amylin and calcitonin receptor agonists for treating diseases and disorders
GB201813677D0 (en) 2018-08-22 2018-10-03 Keybioscience Ag Calcitonin mimetics for treating diseases and disorders
GB201813678D0 (en) 2018-08-22 2018-10-03 Keybioscience Ag Acylated calcitonin mimetics
WO2021026854A1 (zh) * 2019-08-15 2021-02-18 中国科学院微生物研究所 一种酶催化的蛋白质c-端选择性酰肼化修饰方法
GB202001024D0 (en) 2020-01-24 2020-03-11 Key Bioscience Ag Oxyntomodulin mimetics

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374618A (en) * 1983-06-15 1994-12-20 Celltech Limited Calcitonin peptides, and gene related pharmaceutical compositions
DE3327007A1 (de) * 1983-07-27 1985-02-07 Hoechst Ag, 6230 Frankfurt Herstellung von polypeptiden mit einem saeureamid-carboxyterminus
US4708934A (en) * 1984-09-27 1987-11-24 Unigene Laboratories, Inc. α-amidation enzyme
US6319685B1 (en) * 1984-09-27 2001-11-20 Unigene Laboratories, Inc. Alpha-amidating enzyme compositions and processes for their production and use
JPS6229997A (ja) * 1985-04-08 1987-02-07 Sankyo Co Ltd Ｃ末端にプロリンアミドを有するペプチドの製法
JPS62177184A (ja) * 1986-01-29 1987-08-04 Toyota Motor Corp 鋳鉄製内燃機関用シリンダヘツドおよびその製造方法
JPH0775541B2 (ja) * 1986-06-07 1995-08-16 壽之 松尾 Ｃ末端アミド化酵素及びその製造方法
AU7410987A (en) * 1986-06-12 1988-01-07 Immunex Corp. Polypeptides devoid of hydrophobic amino acids
JP2598050B2 (ja) * 1987-07-17 1997-04-09 サントリー株式会社 Ｃ−末端α−アミド化酵素
US5789234A (en) * 1987-08-14 1998-08-04 Unigene Laboratories, Inc. Expression systems for amidating enzyme
US6255067B1 (en) * 1987-09-15 2001-07-03 The Johns Hopkins University cDNA encoding peptidyl-glycine alpha-amidating monooxygenase (PAM)
JP2845468B2 (ja) * 1989-01-17 1999-01-13 サントリー株式会社 ヒト甲状腺由来Ｃ―末端α―アミド化酵素
JP2535398B2 (ja) * 1989-01-17 1996-09-18 サントリー株式会社 アミド化ペプチドの製造方法

Also Published As

Publication number Publication date
FI110517B (fi) 2003-02-14
RU2129606C1 (ru) 1999-04-27
HUT54414A (en) 1991-02-28
ATE283922T1 (de) 2004-12-15
US5789234A (en) 1998-08-04
FI900554A0 (fi) 1990-02-05
ES2235149T3 (es) 2005-07-01
KR0157983B1 (ko) 1998-11-16
JPH0771498B2 (ja) 1995-08-02
DE69034179T2 (de) 2005-12-01
CA2009306C (en) 2002-04-09
LT4077B (en) 1996-12-27
HU900226D0 (en) 1990-03-28
DE69034179D1 (de) 2005-01-05
HU220464B1 (hu) 2002-02-28
NO900531L (no) 1990-08-07
CA2009306A1 (en) 1990-08-06
EP0382403A2 (en) 1990-08-16
EP0382403B1 (en) 2004-12-01
LTIP1829A (en) 1995-08-25
EP0382403A3 (en) 1991-04-10
JPH0541982A (ja) 1993-02-23
NO900531D0 (no) 1990-02-05
KR900013078A (ko) 1990-09-03

Similar Documents

Publication Publication Date Title
NO900531D0 (no) Ekspresjonssystemer for amideringsenzymer.
WO2001014539A3 (en) Methods and compositions for the construction and use of fusion libraries
WO1994003616A3 (fr) Vecteur de clonage et/ou de sequençage
ATE341627T1 (de) Als lerk6 bezeichnetes cytokin
FI923758A0 (fi) Expressionssystem.
FI821466A7 (fi) Bacillus-kloonausvektorit, yhdistelmä- DNA-molekyylit, niiden transformoimat Bacillus-isännät sekä menetelmätvieraiden DNA- sekvenssien ekspressiota varten sekä näiden koodaamien polypeptidien tuottamiseksi.
DE69738514D1 (de) Verbesserte expressionsvektoren
EP0596979A4 (en) Recombinant plant viral nucleic acids.
AU2812484A (en) Dna vectors and there use in recombinant dna technology
IE831211L (en) Cloning vectors for expression of exogenous protein
ATE64619T1 (de) Menschliches apolipoprotein a1 sowie dessen variante, exprimiert in escherichia coli.
BR9609102A (pt) Construção de dna recombinante e vetor útil para produzir transformantes de células de hospedeiro bacteriano
IE890577L (en) Expression of hiv binding proteins
FI971275A7 (fi) Inaktivoidun IVa2-geenin käsittävät epätäydelliset yhdistelmä-DNA-tekn iset adenovirukset
ATE346498T1 (de) Als lerk6 bezeichnetes cytokin
DK169890D0 (da) Kloning og ekspression af et protein, som modulerer det cellulaere respons paa type i interferon
FI885328A0 (fi) Foerfarande foer selektiv spaltning av fusionsproteiner.
DK0672150T3 (da) Modificeret Kluyveromyces-gær, fremstilling og anvendelse
SE8800981D0 (sv) A recombinant fusion protein, its use and a recombinant vector
MY107451A (en) Cloning and expression of a rhoptry associated protein of p.falciparum
IT1262957B (it) Procedimento di produzione della proteina sv-iv ricombinante e proteina sv-iv ricombinante.
DE3688974D1 (de) Expressionssysteme zur überproduktion gewünschter proteine.
IT1261676B (it) Proteine ricombinanti, vettori per l'espressione e loro usi.
WO2001014418A3 (en) p193 PROTEINS AND NUCLEIC ACIDS, AND USES THEREOF
MX9802646A (es) Citocromo c y su gen.